Using VigiBase to Identify Substandard Medicines: Detection Capacity and Key Prerequisites
Drug Safety, Volume 38, No. 4, Year 2015
Notification
URL copied to clipboard!
Results: The assessment of a total of 147 clusters resulted in 8 confirmed, 12 potential and 51 unlikely substandard products, and a further 19 clusters were confirmed as not substandard. Reflecting the difficulty of evaluating suspected substandard products retrospectively when additional information from the primary reporter, as well as samples, are no longer available, 57 clusters were classified as indecisive.